{
  "intermediate": [
    "**Patient Summary:**\n\nPatient Name: RAMANI BHASKARAN\nAge/Gender: 58Y/Female\n\n**Medical History:**\n\n1. **Prediabetes**: The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n2. **Hypertension**: The patient has a systolic blood pressure of 150 mmHg and diastolic blood pressure of 80 mmHg, indicating hypertension.\n3. **Vitamin D Deficiency**: The patient has a Vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n4. **Vitamin B12 Deficiency**: The patient has a Vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n5. **Cervical Spondylosis**: The patient has been diagnosed with cervical spondylosis.\n6. **Bilateral Carotid Plaque**: The patient has bilateral carotid plaques.\n\n**Lab Results:**\n\n1. **Lipid Profile**:\n\t* Total Cholesterol: 170 mg/dL (normal range: 0-199.99 mg/dL)\n\t* Triglycerides: 199 mg/dL (normal range: 0-149.99 mg/dL)\n\t* HDL Cholesterol: 43 mg/dL (normal range: 40-60 mg/dL)\n\t* LDL Cholesterol: 87.2 mg/dL (normal range: 0-100 mg/dL)\n\t* VLDL Cholesterol: 39.8 mg/dL (normal range: 5-30 mg/dL)\n2. **Thyroid Profile**:\n\t* Tri-Iodothyronine (T3, Total): 0.83 ng/mL (normal range: 0.7-2.04 ng/mL)\n\t* Thyroxine (T4, Total): 7.43 µg/dL (normal range: 5.48-14.28 µg/dL)\n\t* Thyroid Stimulating Hormone (TSH): 3.931 µIU/mL (normal range: 0.34-5.6 µIU/mL)\n3. **Complete Blood Count (CBC)**:\n\t* Lymphocytes: 28.8% (normal range: 20-40%)\n\t* Neutrophils: 4882.2 cells/cu.mm (normal range: 2000-7000 cells/cu.mm)\n\t* Monocytes: 5.6% (normal range: 2-10%)\n\t* Basophils: 0.7% (normal range: 0-2%)\n4. **Blood Urea Nitrogen**: 16.00 mg/dL (normal range: 17-43 mg/dL)\n5. **Urine Examination**:\n\t* Colour: Pale Yellow\n\t* Transparency: Clear\n\t* Urine Protein: Negative\n\t* Glucose: Negative\n\t* Urine Bilirubin: Negative\n\t* Urine Ketones (Random): Negative\n\t* Urobilinogen: Normal\n\t* Blood: Negative\n\t* Nitrite: Negative\n\t* Leucocyte Esterase: Negative\n\t* Pus Cells: 1-3\n\t* Epithelial Cells: 2-4\n\t* RBC: Nil\n\t* Casts: Absent\n\t* Crystals: Absent\n\t* pH: 5.5 (normal range: 5-7.5)\n\t* Specific Gravity: 1.025 (normal range: 1.002-1.03)\n\n**Recommendations:**\n\n1. **Lifestyle Modifications**: The patient should adopt a healthy lifestyle, including a balanced diet, regular exercise, and stress management.\n2. **Medications**: The patient should be prescribed medications to manage hypertension, vitamin D deficiency, and vitamin B12 deficiency.\n3. **Follow-up**: The patient should follow up with the doctor for regular check-ups and to monitor the progression of the disease.\n4. **Dietary Changes**: The patient should make dietary changes to manage triglyceride levels and improve overall health.\n5. **Regular Exercise**: The patient should engage in regular exercise to improve cardiovascular health and manage weight.\n\n**Disclaimer:** The above summary is based on the provided medical report and is subject to clinical interpretation by a qualified medical professional.",
    "**Summary of Medical Report**\n\n**Patient Information:** \nUnfortunately, the patient's name and demographic details are not provided in the report.\n\n**Laboratory Tests:**\n\n1. **Urine Analysis:**\n   - The urine sample is negative for pus cells, epithelial cells, RBC, casts, and crystals.\n   - pH: 5.5 (within normal range: 5-7.5)\n   - Specific gravity: 1.025 (within normal range: 1.002-1.03)\n\n2. **Complete Blood Count (CBC):**\n   - Total Leucocyte Count (TLC): 7,900 cells/cu.mm (within normal range: 4,000-11,000 cells/cu.mm)\n   - Haemoglobin: 12 g/dL (within normal range: 12-15 g/dL)\n   - PCV: 35.90% (within normal range: 36-46%)\n   - RBC count: 4.07 million/cu.mm (within normal range: 3.8-4.8 million/cu.mm)\n   - MCV: 88.4 fL (within normal range: 83-101 fL)\n   - MCH: 29.5 pg (within normal range: 27-32 pg)\n   - MCHC: 33.3 g/dL (within normal range: 31.5-34.5 g/dL)\n   - R.D.W: 14.6% (within normal range: 11.6-14%)\n\n3. **Vitamin D Test:**\n   - Vitamin D level: 15.4 ng/mL (within normal range: 30-100 ng/mL)\n\n4. **Fasting Glucose Test:**\n   - Fasting glucose: 100 mg/dL (within normal range: 70-100 mg/dL)\n\n5. **HbA1c Test:**\n   - HbA1c: 6.2% (within normal range: 0-0%)\n   - Estimated Average Glucose (eAG): 131 mg/dL (within normal range: 0-0 mg/dL)\n\n6. **Renal Function Test (RFT):**\n   - Creatinine: 0.74 mg/dL (within normal range: 0.72-1.18 mg/dL)\n   - Urea: 16.00 mg/dL (within normal range: 17-43 mg/dL)\n   - Blood Urea Nitrogen (BUN): 7.5 mg/dL (within normal range: 8-23 mg/dL)\n   - Uric Acid: 5.90 mg/dL (within normal range: 2.6-6 mg/dL)\n   - Calcium: 9.90 mg/dL (within normal range: 8.8-10.6 mg/dL)\n   - Phosphorus: 4.00 mg/dL (within normal range: 2.5-4.5 mg/dL)\n   - Sodium: 139 mmol/L (within normal range: 136-146 mmol/L)\n   - Potassium: 4.5 mmol/L (within normal range: 3.5-5.1 mmol/L)\n   - Chloride: 103 mmol/L (within normal range: 101-109 mmol/L)\n\n7. **Liver Function Test (LFT):**\n   - Bilirubin, Total: 0.47 mg/dL (within normal range: 0.3-1.2 mg/dL)\n   - Bilirubin, Conjugated (Direct): 0.10 mg/dL (within normal range: 0-0.19 mg/dL)\n   - Bilirubin (Indirect): 0.37 mg/dL (within normal range: 0-1.1 mg/dL)\n   - Alanine Aminotransferase (ALT/SGPT): 15 U/L (within normal range: 0-34.99 U/L)\n   - Aspartate Aminotransferase (AST/SGOT): 15.0 U/L (within normal range: 0-34.99 U/L)\n   - Alkaline Phosphatase: 67.00 U/L (within normal range: 30-120 U/L)\n   - Protein, Total: 7.50 g/dL (within normal range: 6.6-8.3 g/dL)\n   - Albumin: 4.50 g/dL (within normal range: 3.5-5.2 g/dL)\n   - Globulin: 3.00 g/dL (within normal range: 2-3.5 g/dL)\n   - A/G Ratio: 1.5 (within normal range: 0.9-2)\n\n8. **CA-125 Test:**\n   - CA-125: 6.3 U/mL (within normal range: 0-35 U/mL)\n\n**Risk Scores:**\n\n1. **AICVD Risk Score:** Low Risk\n2. **Pre-Diabetes Risk Score:** Low Risk\n3. **COPD Risk Assessment:** Low Risk\n\n**Interpretation:**\n\nThe patient's laboratory tests are largely within normal limits. However, the patient's fasting glucose level is slightly elevated, which may indicate impaired glucose tolerance or pre-diabetes. The patient's HbA1c level is also slightly elevated, which may indicate poor glycemic control. The patient's renal function tests are within normal limits, and the liver function tests are also within normal limits. The patient's risk scores for cardiovascular disease, pre-diabetes, and COPD are all low.\n\n**Recommendations:**\n\n1. The patient should undergo further evaluation for impaired glucose tolerance or pre-diabetes, including a 75-g oral glucose tolerance test (OGTT).\n2. The patient should be educated on lifestyle modifications to improve glycemic control, including diet and exercise.\n3. The patient should be monitored regularly for changes in renal function and liver function.\n4. The patient should be educated on the risks and benefits of screening for cardiovascular disease, pre-diabetes, and COPD.\n\n**Disclaimer:**\n\nThis summary is based on the provided medical report and is subject to clinical interpretation by qualified medical professionals. The report is not subject to use for any medicolegal purpose."
  ],
  "consolidated": "**Comprehensive Medical Summary:**\n\n**Patient Information:**\n\nUnfortunately, the patient's name and demographic details are not provided in the report.\n\n**Medical History:**\n\n1. **Prediabetes**: The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n2. **Hypertension**: The patient has a systolic blood pressure of 150 mmHg and diastolic blood pressure of 80 mmHg, indicating hypertension.\n3. **Vitamin D Deficiency**: The patient has a Vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n4. **Vitamin B12 Deficiency**: The patient has a Vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n5. **Cervical Spondylosis**: The patient has been diagnosed with cervical spondylosis.\n6. **Bilateral Carotid Plaque**: The patient has bilateral carotid plaques.\n\n**Lab Results:**\n\n1. **Lipid Profile**:\n\t* Total Cholesterol: 170 mg/dL (normal range: 0-199.99 mg/dL)\n\t* Triglycerides: 199 mg/dL (normal range: 0-149.99 mg/dL)\n\t* HDL Cholesterol: 43 mg/dL (normal range: 40-60 mg/dL)\n\t* LDL Cholesterol: 87.2 mg/dL (normal range: 0-100 mg/dL)\n\t* VLDL Cholesterol: 39.8 mg/dL (normal range: 5-30 mg/dL)\n2. **Thyroid Profile**:\n\t* Tri-Iodothyronine (T3, Total): 0.83 ng/mL (normal range: 0.7-2.04 ng/mL)\n\t* Thyroxine (T4, Total): 7.43 µg/dL (normal range: 5.48-14.28 µg/dL)\n\t* Thyroid Stimulating Hormone (TSH): 3.931 µIU/mL (normal range: 0.34-5.6 µIU/mL)\n3. **Complete Blood Count (CBC)**:\n\t* Lymphocytes: 28.8% (normal range: 20-40%)\n\t* Neutrophils: 4882.2 cells/cu.mm (normal range: 2000-7000 cells/cu.mm)\n\t* Monocytes: 5.6% (normal range: 2-10%)\n\t* Basophils: 0.7% (normal range: 0-2%)\n4. **Blood Urea Nitrogen**: 16.00 mg/dL (normal range: 17-43 mg/dL)\n5. **Urine Examination**:\n\t* Colour: Pale Yellow\n\t* Transparency: Clear\n\t* Urine Protein: Negative\n\t* Glucose: Negative\n\t* Urine Bilirubin: Negative\n\t* Urine Ketones (Random): Negative\n\t* Urobilinogen: Normal\n\t* Blood: Negative\n\t* Nitrite: Negative\n\t* Leucocyte Esterase: Negative\n\t* Pus Cells: 1-3\n\t* Epithelial Cells: 2-4\n\t* RBC: Nil\n\t* Casts: Absent\n\t* Crystals: Absent\n\t* pH: 5.5 (normal range: 5-7.5)\n\t* Specific Gravity: 1.025 (normal range: 1.002-1.03)\n\n**Imaging Findings:**\n\n1. **Bilateral Carotid Plaque**: The patient has bilateral carotid plaques.\n\n**Diagnoses:**\n\n1. **Hypertension**: The patient has a systolic blood pressure of 150 mmHg and diastolic blood pressure of 80 mmHg, indicating hypertension.\n2. **Vitamin D Deficiency**: The patient has a Vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n3. **Vitamin B12 Deficiency**: The patient has a Vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n4. **Cervical Spondylosis**: The patient has been diagnosed with cervical spondylosis.\n5. **Prediabetes**: The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n\n**Treatments:**\n\n1. **Lifestyle Modifications**: The patient should adopt a healthy lifestyle, including a balanced diet, regular exercise, and stress management.\n2. **Medications**: The patient should be prescribed medications to manage hypertension, vitamin D deficiency, and vitamin B12 deficiency.\n3. **Follow-up**: The patient should follow up with the doctor for regular check-ups and to monitor the progression of the disease.\n4. **Dietary Changes**: The patient should make dietary changes to manage triglyceride levels and improve overall health.\n5. **Regular Exercise**: The patient should engage in regular exercise to improve cardiovascular health and manage weight.\n\n**Recommendations:**\n\n1. **Further Evaluation**: The patient should undergo further evaluation for impaired glucose tolerance or pre-diabetes, including a 75-g oral glucose tolerance test (OGTT).\n2. **Lifestyle Modifications**: The patient should be educated on lifestyle modifications to improve glycemic control, including diet and exercise.\n3. **Regular Monitoring**: The patient should be monitored regularly for changes in renal function and liver function.\n4. **Screening**: The patient should be educated on the risks and benefits of screening for cardiovascular disease, pre-diabetes, and COPD.\n\n**Disclaimer:**\n\nThis summary is based on the provided medical report and is subject to clinical interpretation by qualified medical professionals. The report is not subject to use for any medicolegal purpose.",
  "final": "**Verification of Provided Chunks:**\n\nAfter reviewing the provided chunks, I found the following missing or ambiguous information:\n\n1. c_5b30e22a676d: Missing - Patient's name and demographic details.\n2. c_704666729238: Ambiguous - The report does not specify the exact date of the medical examination.\n3. c_14ec6f1cbff4: Ambiguous - The report does not specify the exact date of the medical examination.\n4. c_53ebd27470ac: Missing - The report does not mention any specific medications prescribed for hypertension, vitamin D deficiency, or vitamin B12 deficiency.\n5. c_7bc39f9c0b04: Ambiguous - The report does not specify the exact date of the medical examination.\n6. c_a7a9daab6464: Missing - The report does not mention any specific dietary changes recommended for the patient.\n7. c_a43e0f94dbdf: Ambiguous - The report does not specify the exact date of the medical examination.\n8. c_868a0abe96aa: Missing - The report does not mention any specific regular exercise plan recommended for the patient.\n9. c_f1b4602afaf7: Ambiguous - The report does not specify the exact date of the medical examination.\n10. c_583d260a0687: Missing - The report does not mention any specific follow-up schedule for the patient.\n11. c_f81a1570da7d: Ambiguous - The report does not specify the exact date of the medical examination.\n12. c_280c5edcc6d3: Missing - The report does not mention any specific further evaluation recommended for the patient.\n13. c_9d8ff20e1175: Ambiguous - The report does not specify the exact date of the medical examination.\n14. c_d1d8340b272b: Missing - The report does not mention any specific regular monitoring schedule for the patient.\n15. c_acabcddda255: Ambiguous - The report does not specify the exact date of the medical examination.\n16. c_b3459a555895: Missing - The report does not mention any specific screening tests recommended for the patient.\n17. c_390101235fb8: Ambiguous - The report does not specify the exact date of the medical examination.\n18. c_10963c14b27d: Missing - The report does not mention any specific lifestyle modifications recommended for the patient.\n19. c_9b454bc0222b: Ambiguous - The report does not specify the exact date of the medical examination.\n20. c_5440eae0d144: Missing - The report does not mention any specific follow-up schedule for the patient.\n21. c_b42141c0037d: Ambiguous - The report does not specify the exact date of the medical examination.\n22. c_3460efad295f: Missing - The report does not mention any specific regular exercise plan recommended for the patient.\n23. c_b3629058548b: Ambiguous - The report does not specify the exact date of the medical examination.\n24. c_5f8f44d14f0d: Missing - The report does not mention any specific dietary changes recommended for the patient.\n25. c_1b3f391f408d: Ambiguous - The report does not specify the exact date of the medical examination.\n26. c_48f676416909: Missing - The report does not mention any specific follow-up schedule for the patient.\n27. c_29efad2e4c13: Ambiguous - The report does not specify the exact date of the medical examination.\n\n**Polished Summary:**\n\n**Patient Information:**\n\nUnfortunately, the patient's name and demographic details are not provided in the report.\n\n**Medical History:**\n\n1. **Prediabetes**: The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n2. **Hypertension**: The patient has a systolic blood pressure of 150 mmHg and diastolic blood pressure of 80 mmHg, indicating hypertension.\n3. **Vitamin D Deficiency**: The patient has a Vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n4. **Vitamin B12 Deficiency**: The patient has a Vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n5. **Cervical Spondylosis**: The patient has been diagnosed with cervical spondylosis.\n6. **Bilateral Carotid Plaque**: The patient has bilateral carotid plaques.\n\n**Lab Results:**\n\n1. **Lipid Profile**:\n\t* Total Cholesterol: 170 mg/dL (normal range: 0-199.99 mg/dL)\n\t* Triglycerides: 199 mg/dL (normal range: 0-149.99 mg/dL)\n\t* HDL Cholesterol: 43 mg/dL (normal range: 40-60 mg/dL)\n\t* LDL Cholesterol: 87.2 mg/dL (normal range: 0-100 mg/dL)\n\t* VLDL Cholesterol: 39.8 mg/dL (normal range: 5-30 mg/dL)\n2. **Thyroid Profile**:\n\t* Tri-Iodothyronine (T3, Total): 0.83 ng/mL (normal range: 0.7-2.04 ng/mL)\n\t* Thyroxine (T4, Total): 7.43 µg/dL (normal range: 5.48-14.28 µg/dL)\n\t* Thyroid Stimulating Hormone (TSH): 3.931 µIU/mL (normal range: 0.34-5.6 µIU/mL)\n3. **Complete Blood Count (CBC)**:\n\t* Lymphocytes: 28.8% (normal range: 20-40%)\n\t* Neutrophils: 4882.2 cells/cu.mm (normal range: 2000-7000 cells/cu.mm)\n\t* Monocytes: 5.6% (normal range: 2-10%)\n\t* Basophils: 0.7% (normal range: 0-2%)\n4. **Blood Urea Nitrogen**: 16.00 mg/dL (normal range: 17-43 mg/dL)\n5. **Urine Examination**:\n\t* Colour: Pale Yellow\n\t* Transparency: Clear\n\t* Urine Protein: Negative\n\t* Glucose: Negative\n\t* Urine Bilirubin: Negative\n\t* Urine Ketones (Random): Negative\n\t* Urobilinogen: Normal\n\t* Blood: Negative\n\t* Nitrite: Negative\n\t* Leucocyte Esterase: Negative\n\t* Pus Cells: 1-3\n\t* Epithelial Cells: 2-4\n\t* RBC: Nil\n\t* Casts: Absent\n\t* Crystals: Absent\n\t* pH: 5.5 (normal range: 5-7.5)\n\t* Specific Gravity: 1.025 (normal range: 1.002-1.03)\n\n**Imaging Findings:**\n\n1. **Bilateral Carotid Plaque**: The patient has bilateral carotid plaques.\n\n**Diagnoses:**\n\n1. **Hypertension**: The patient has a systolic blood pressure of 150 mmHg and diastolic blood pressure of 80 mmHg, indicating hypertension.\n2. **Vitamin D Deficiency**: The patient has a Vitamin D level of 15.4 ng/mL, which is below the normal range of 30-100 ng/mL.\n3. **Vitamin B12 Deficiency**: The patient has a Vitamin B12 level of 50 pg/mL, which is below the normal range of 120-914 pg/mL.\n4. **Cervical Spondylosis**: The patient has been diagnosed with cervical spondylosis.\n5. **Prediabetes**: The Apollo Hospitals Prediabetes Risk tool has assessed a risk score of 2.5/100, indicating a low risk for undiagnosed prediabetes.\n\n**Treatments:**\n\n1. **Lifestyle Modifications**: The patient should adopt a healthy lifestyle, including a balanced diet, regular exercise, and stress management.\n2. **Medications**: The patient should be prescribed medications to manage hypertension, vitamin D deficiency, and vitamin B12 deficiency.\n3. **Follow-up**: The patient should follow up with the doctor for regular check-ups and to monitor the progression of the disease.\n4. **Dietary Changes**: The patient should make dietary changes to manage triglyceride levels and improve overall health.\n5. **Regular Exercise**: The patient should engage in regular exercise to improve cardiovascular health and manage weight.\n\n**Recommendations:**\n\n1. **Further Evaluation**: The patient should undergo further evaluation for impaired glucose tolerance or pre-diabetes, including a 75-g oral glucose tolerance test (OGTT).\n2. **Lifestyle Modifications**: The patient should be educated on lifestyle modifications to improve glycemic control, including diet and exercise.\n3. **Regular Monitoring**: The patient should be monitored regularly for changes in renal function and liver function.\n4. **Screening**: The patient should be educated on the risks and benefits of screening for cardiovascular disease, pre-diabetes, and COPD.\n\n**Disclaimer:**\n\nThis summary is based on the provided medical report and is subject to clinical interpretation by qualified medical professionals. The report is not subject to use for any medicolegal purpose."
}